Vaccines
7 August 2014
Soligenix Advances Development of a Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax31 July 2014
First Clinical Data of Therapeutic Parkinson’s Disease Vaccine Encourages Continued Development24 July 2014
Bavarian Nordic Announces First Patient Treated in a Phase 1 Study of MVA-BN(r) Brachyury in Advanced Cancer22 July 2014
Genocea HSV-2 Immunotherapeutic GEN-003 Elicits Significant, Durable T Cell Responses in Vaccinated Subjects11 July 2014
Genticel’s Phase II study with ProCervix passes the halfway mark for patient recruitment9 July 2014
Soligenix Announces Combination Vaccine for Ricin and Anthrax Achieves Simultaneous Protection9 July 2014
Protein Sciences Receives Approval from FDA for 2014/15 Formulation of Flublok® Influenza Vaccine26 June 2014
Agenus Vaccine Shows Significant Reduction in Viral Burden after HerpV Generated Immune ActivationNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports